Your browser doesn't support javascript.
loading
[Treatment Methods for Dystonia, Myoclonus, and Chorea].
Hasegawa, Kazuko.
Afiliación
  • Hasegawa K; Department of Neurology, National Hospital Organization Sagamihara National Hospital.
Brain Nerve ; 75(5): 542-548, 2023 May.
Article en Ja | MEDLINE | ID: mdl-37194528
ABSTRACT
Abnormal involuntary movement (AIM) are usually classified into hypokinesia and hyperkinesia group. Hyperkinesia-AIM includes myoclonus, chorea, ballism, dystonia, athetosis, and more. Of these, dystonia, myoclonus, and chorea are frequent movement disorders. From a neurophysiological point of view, the mechanism of motor control by the basal ganglia is thought to consist of three pathways hyperdirect, direct, and indirect. Hyperkinetic-AIMs are likely caused by the dysfunction of any of these three pathways, leading to malfunction in either presurround inhibition, initiation of motor performance, or postsurround inhibition. These dysfunctions are assumed to stem from regions, such as the cerebral cortex, white matter, basal ganglia, brainstem, and cerebellum. Drug therapies that consider the pathogenesis mechanism are desirable. Here, we presented an overview of treatment methods for hyperkinetic-AIMs.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corea / Discinesias / Distonía / Trastornos del Movimiento / Mioclonía Límite: Humans Idioma: Ja Revista: Brain Nerve Asunto de la revista: CEREBRO / NEUROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corea / Discinesias / Distonía / Trastornos del Movimiento / Mioclonía Límite: Humans Idioma: Ja Revista: Brain Nerve Asunto de la revista: CEREBRO / NEUROLOGIA Año: 2023 Tipo del documento: Article